Skip to main content
OpenTrials
Completed

NCT Number: NCT03028558

Biology of the Oral Epithelium of E-Cigarette Smokers

Electronic cigarettes (EC) are battery powered nicotine delivery devices that aerosolize nicotine and other flavor constituents. Despite the increasing use of EC, little attention has been paid to their possible adverse effects on human health. Theoretically, the risk relates to nicotine per se and/or the propellants or contaminants in the EC aerosol. The hypothesis underlying the proposal is that chronic EC smoking disorders the biology of the oral epithelium, the first cell population exposed to inhaled EC vapors. Using a cross-sectional, cohort-comparison of EC smokers compared to age-, gender- and ethnicity-matched never smokers, the investigators propose to assess the oral epithelium obtained by punch biopsy or brushing from 100 EC smokers and 25 nonsmoker controls. The EC study cohort will be restricted to young adults (age 21-35 yr) with no prior history of tobacco smoking, but who have smoked EC for >6 months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–35 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Genetic Medicine, Weill Cornell Medical College

New York, 10021, United States

About this study

There is compelling evidence to support this hypothesis: (1) EC vapors contain nicotine, the oral epithelium expresses nicotine receptors, and exposure of epithelia to nicotine activates the nicotine pathway; (2) EC vapors also contain chemical contaminants that can potentially effect oral epithelial biology; and (3) in vitro studies suggest that EC vapors modify epithelial biology and data generated by our laboratory demonstrates that even a brief, acute exposure of healthy nonsmokers to EC vapors induces significant changes in the airway epithelial transcriptome, including the expression of genes in the nicotine and p53 pathways. With the knowledge that disordering of cell biology occurs long before clinical disease,the investigators will evaluate the oral epithelium at the transcriptome (mRNA and miRNA) levels. They will then identify gene(s)/pathways/communities disordered by EC vapors.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HEALTHY VOLUNTEER RESEARCH SUBJECTS:

Inclusion criteria

  • Males and females, ages 21 to 35
  • Must be capable of providing informed consent
  • Self-reported never-smokers of any type, including chewing tobacco, with current smoking status validated by the absence of nicotine metabolites in urine (nicotine <2 ng/ml and cotinine <5 ng/ml)
  • No bleeding diathesis
  • Normal physical examination
  • Good overall health without history of oral or lung disease
  • Normal routine laboratory evaluation, including general hematologic studies, general serologic/immunologic studies, general biochemical analyses, and urine analysis
  • Not taking any medications relevant to lung disease or having an effect on the airway epithelium
  • Normal chest X-ray (PA and lateral)
  • Normal electrocardiogram (sinus bradycardia, premature atrial contractions are permissible)
  • Females - not pregnant
  • Willingness to participate in the study
  • HEALTHY VOLUNTEER E-CIGARETTE SMOKING SUBJECTS:

Inclusion criteria

  • Males and females, ages 21 to 35
  • Must be capable of providing informed consent
  • E-cigarette smokers with current smoking status validated by nicotine metabolites in urine (nicotine >20 ng/ml and cotinine >30 ng/ml)
  • No bleeding diathesis
  • Normal routine laboratory evaluation, including general hematologic studies, general serologic/immunologic studies, general biochemical analyses, and urine analysis
  • Good overall health without history of oral disease
  • Normal spirometry
  • All individuals have chest X-ray (PA and lateral)
  • Normal electrocardiogram (sinus bradycardia, premature atrial contractions are permissible)
  • Females - not pregnant
  • Willingness to participate in the study

Exclusion criteria

  • HEALTHY VOLUNTEER RESEARCH SUBJECTS:

Exclusion criteria

  • Unable to meet the inclusion criteria
  • Have smoked any form of tobacco
  • Current marijuana smokers (within the last three months)
  • Current active infection or acute illness of any kind
  • Evidence of malignancy, including oral cancer
  • Current pregnancy
  • HEALTHY VOLUNTEER E-CIGARETTE SMOKING SUBJECTS:

Exclusion criteria

  • Unable to meet the inclusion criteria
  • Have smoked any form of tobacco
  • Current marijuana smokers (within the last three months)
  • Current active infection or acute illness of any kind
  • Evidence of malignancy, including oral cancer
  • Current Pregnancy

Treatment and study plan

Primary outcomes

  1. The biology of participants oral epithelial cells

    Time frame: 1-2 months

    Biopsies will be collected from the buccal mucosa of chronic EC smokers and healthy nonsmoker controls, none of whom have a history of smoking any tobacco products

Secondary outcomes

  1. The biology of the genes of the oral epithelium

    Time frame: 1-2 months

    Biopsies will be collected from the buccal mucosa of chronic EC smokers and healthy nonsmoker controls, none of whom have a history of smoking any tobacco products

Sponsors and collaborators

Lead sponsor

Weill Medical College of Cornell University

Other

Registry information

Important dates

Study start
2016
Primary completion
2019
Study completion
2021
First posted
Jan 23, 2017
Registry last updated
May 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.